about
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsA systematic study of the polyphenolic composition of aqueous extracts deriving from several Cistus genus species: evolutionary relationship.Validation of the AlamarBlue® Assay as a Fast Screening Method to Determine the Antimicrobial Activity of Botanical Extracts.Evaluation of the intestinal permeability of rosemary (Rosmarinus officinalis L.) extract polyphenols and terpenoids in Caco-2 cell monolayers.Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivoMolecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties.Lemon balm extract (Melissa officinalis, L.) promotes melanogenesis and prevents UVB-induced oxidative stress and DNA damage in a skin cell model.Differential metabolomic analysis of the potential antiproliferative mechanism of olive leaf extract on the JIMT-1 breast cancer cell line.Protective effects of citrus and rosemary extracts on UV-induced damage in skin cell model and human volunteers.IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations.Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS.An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cytotoxic activity against human cancer cells.Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.The promiscuous and synergic molecular interaction of polyphenols in bactericidal activity: an opportunity to improve the performance of antibiotics?Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity.Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications.Polyphenols as Promising Drugs against Main Breast Cancer Signatures.Nutraceuticals for Skin Care: A Comprehensive Review of Human Clinical Studies.Correlation between the antibacterial activity and the composition of extracts derived from various Spanish Cistus species.New Mammalian Target of Rapamycin (mTOR) Modulators Derived from Natural Product Databases and Marine Extracts by Using Molecular Docking TechniquesHigh-performance liquid chromatography with diode array detection coupled to electrospray time-of-flight and ion-trap tandem mass spectrometry to identify phenolic compounds from a Cistus ladanifer aqueous extractBioavailability study of a polyphenol-enriched extract from Hibiscus sabdariffa in rats and associated antioxidant statusIn vitro duodenal lipolysis of lipid-based drug delivery systems studied by HPLC-UV and HPLC-MSInfluence of olive leaf processing on the bioaccessibility of bioactive polyphenolsThe Multitarget Activity of Natural Extracts on Cancer: Synergy and XenohormesisMarine Invertebrate Extracts Induce Colon Cancer Cell Death via ROS-Mediated DNA Oxidative Damage and Mitochondrial ImpairmentRosemary Diterpenes and Flavanone Aglycones Provide Improved Genoprotection against UV-Induced DNA Damage in a Human Skin Cell ModelThe Potential Synergistic Modulation of AMPK by Lippia citriodora Compounds as a Target in Metabolic DisordersNatural Compounds as New Cancer TreatmentsPreclinical Evaluation of the Antimicrobial-Immunomodulatory Dual Action of Xenohormetic Molecules against Haemophilus influenzae Respiratory Infection
P50
Q28395443-483C9FD0-C806-4ACA-90BE-596C648E05EAQ34160448-C93342B3-DD21-4590-BDC9-24B14BE02AB2Q36235808-EB6B036F-43AB-4FDE-A645-94D7C3B66911Q36289570-07C2D66F-2C02-4031-9C26-411813B8FDCEQ37107787-0DDF65B3-8BF8-4DF3-8126-050614DF2E4FQ38231266-92124F20-5D0C-4D9C-B23F-A21FD5B44321Q38751596-39115094-B591-4879-B93E-5A207E717FC8Q38922998-3282E96A-E6D4-4885-97E3-1B4E073C3EE2Q38996468-39917156-1585-4C72-B0C0-99EE8EB5F55DQ39101764-17430522-00DF-43E2-B7BE-E64BA3A17936Q39115260-CAC5C99F-EBF9-467C-B2BC-69B2E53E07CCQ39245871-5ADF91C0-4FF7-48A8-9DF4-6E9A24D468C8Q39394159-593A975B-1CAE-4528-85B4-6356FE4688BDQ39698987-36CEC4DD-14BA-4D32-AB3F-D764F4A0B9BCQ39778072-32020B81-B966-48DE-BB42-CD14F7735D9CQ41519431-10E00944-95D7-4D63-A12F-EF4741BC7CD9Q41584436-4B98A1EA-98B0-4E7D-81D4-40DF27BF9334Q41878464-66517AD5-5C24-4546-8523-91B5D9C22B4BQ42800458-090041F4-81F1-44AA-A4EE-1861333DCBAAQ47136288-FC62CAEF-A3AE-4CD3-B0AD-634A827AB34EQ51758975-3498F99B-8809-4716-9996-E8B62BACED5EQ54318709-DE3DABF6-DC55-4C08-9487-41873DD4A0B5Q57464348-E2410DEB-C7EA-40B0-81B6-BA0A3E559C67Q82357324-FFDD476C-51FE-442C-B094-72D4C067C3E7Q84797111-7E8B1AE2-5613-45BC-8002-9CDD76D852AFQ87341752-76C736E2-CF6D-4E0D-8B92-DBB20E58DC39Q88073757-C500E0B4-F7B0-43E8-9196-DEB915F40FABQ90829650-0174D962-4CCA-4DFB-AB83-D82FE38AC9BFQ91468369-77AE6728-8579-487E-BF39-0A31F7574314Q91547755-BE981F83-E8AD-4626-8CF3-7E735B696FA8Q91810020-2FF7D499-3E19-4F44-8284-10718FC8517DQ92150454-E0E6FF9A-C61E-47BB-BE72-57DDCCA9E575Q92152620-3BA486D1-CDC9-40D0-AA26-3C43EA77FF31
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Enrique Barrajón-Catalán
@ast
Enrique Barrajón-Catalán
@en
Enrique Barrajón-Catalán
@es
Enrique Barrajón-Catalán
@nl
Enrique Barrajón-Catalán
@sl
type
label
Enrique Barrajón-Catalán
@ast
Enrique Barrajón-Catalán
@en
Enrique Barrajón-Catalán
@es
Enrique Barrajón-Catalán
@nl
Enrique Barrajón-Catalán
@sl
prefLabel
Enrique Barrajón-Catalán
@ast
Enrique Barrajón-Catalán
@en
Enrique Barrajón-Catalán
@es
Enrique Barrajón-Catalán
@nl
Enrique Barrajón-Catalán
@sl
P1053
C-2884-2013
P106
P1153
35809863200
P21
P31
P3829
P496
0000-0001-8113-0795
P569
2000-01-01T00:00:00Z